489 related articles for article (PubMed ID: 18497941)
1. New radiosensitization treatment (KORTUC I) using hydrogen peroxide solution-soaked gauze bolus for unresectable and superficially exposed neoplasms.
Ogawa Y; Ue H; Tsuzuki K; Tadokoro M; Miyatake K; Sasaki T; Yokota N; Hamada N; Kariya S; Hitomi J; Nishioka A; Nakajima K; Ikeda M; Sano S; Inomata T
Oncol Rep; 2008 Jun; 19(6):1389-94. PubMed ID: 18497941
[TBL] [Abstract][Full Text] [Related]
2. Safety and effectiveness of a new enzyme-targeting radiosensitization treatment (KORTUC II) for intratumoral injection for low-LET radioresistant tumors.
Ogawa Y; Kubota K; Ue H; Tadokoro M; Matsui R; Yamanishi T; Hamada N; Kariya S; Nishioka A; Nakajima H; Tarutani M; Sano S
Int J Oncol; 2011 Sep; 39(3):553-60. PubMed ID: 21667020
[TBL] [Abstract][Full Text] [Related]
3. Phase I study of a new radiosensitizer containing hydrogen peroxide and sodium hyaluronate for topical tumor injection: a new enzyme-targeting radiosensitization treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II).
Ogawa Y; Kubota K; Ue H; Kataoka Y; Tadokoro M; Miyatake K; Tsuzuki K; Yamanishi T; Itoh S; Hitomi J; Hamada N; Kariya S; Fukumoto M; Nishioka A; Inomata T
Int J Oncol; 2009 Mar; 34(3):609-18. PubMed ID: 19212665
[TBL] [Abstract][Full Text] [Related]
4. Non-surgical care for locally advanced breast cancer: radiologically assessed therapeutic outcome of a new enzyme-targeting radiosensitization treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II) with systemic chemotherapy.
Miyatake K; Kubota K; Ogawa Y; Hamada N; Murata Y; Nishioka A
Oncol Rep; 2010 Nov; 24(5):1161-8. PubMed ID: 20878106
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic response to a novel enzyme-targeting radiosensitization treatment (Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas) in patients with recurrent breast cancer.
Aoyama N; Ogawa Y; Yasuoka M; Takahashi M; Iwasa H; Miyatake K; Yamanishi T; Hamada N; Tamura T; Nishioka A; Yamagami T
Oncol Lett; 2016 Jul; 12(1):29-34. PubMed ID: 27347095
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic-resistance of the human osteosarcoma cell line HS-Os-1 to irradiation is converted to apoptotic-susceptibility by hydrogen peroxide: a potent role of hydrogen peroxide as a new radiosensitizer.
Ogawa Y; Takahashi T; Kobayashi T; Kariya S; Nishioka A; Ohnishi T; Saibara T; Hamasato S; Tani T; Seguchi H; Yoshida S; Sonobe H
Int J Mol Med; 2003 Dec; 12(6):845-50. PubMed ID: 14612955
[TBL] [Abstract][Full Text] [Related]
7. Development of a novel enzyme-targeting radiosensitizer (KORTUC) containing hydrogen peroxide for intratumoral injection for patients with low linear energy transfer-radioresistant neoplasms.
Tokuhiro S; Ogawa Y; Tsuzuki K; Akima R; Ue H; Kariya S; Nishioka A
Oncol Lett; 2010 Nov; 1(6):1025-1028. PubMed ID: 22870106
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic results of a novel enzyme-targeting radiosensitization treatment, Kochi oxydol-radiation therapy for unresectable carcinomas II, in patients with stage I primary breast cancer.
Aoyama N; Ogawa Y; Yasuoka M; Ohgi K; Iwasa H; Miyatake K; Yoshimatsu R; Yamanishi T; Hamada N; Tamura T; Kobayashi K; Murata Y; Miyamura M; Yamagami T
Oncol Lett; 2017 Jun; 13(6):4741-4747. PubMed ID: 28599475
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic response to a novel enzyme-targeting radiosensitization treatment (KORTUC II) for residual lesions in patients with stage IV primary breast cancer, following induction chemotherapy with epirubicin and cyclophosphamide or taxane.
Aoyama N; Ogawa Y; Yasuoka M; Iwasa H; Miyatake K; Yoshimatsu R; Yamanishi T; Hamada N; Tamura T; Kobayashi K; Murata Y; Yamagami T; Miyamura M
Oncol Lett; 2017 Jan; 13(1):69-76. PubMed ID: 28123524
[TBL] [Abstract][Full Text] [Related]
10. [Clinical results of thermoradiotherapy of locally advanced and recurrent breast cancers--comparison of results with radiotherapy alone].
Masunaga S; Hiraoka M; Takahashi M; Jo S; Akuta K; Nishimura Y; Nagata Y; Abe M
Nihon Igaku Hoshasen Gakkai Zasshi; 1989 Mar; 49(3):304-13. PubMed ID: 2755796
[TBL] [Abstract][Full Text] [Related]
11. Serial Assessment of Therapeutic Response to a New Radiosensitization Treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II), in Patients with Stage I/II Breast Cancer Using Breast Contrast-Enhanced Magnetic Resonance Imaging.
Yaogawa S; Ogawa Y; Morita-Tokuhiro S; Tsuzuki A; Akima R; Itoh K; Morio K; Yasunami H; Onogawa M; Kariya S; Nogami M; Nishioka A; Miyamura M
Cancers (Basel); 2015 Dec; 8(1):. PubMed ID: 26703733
[TBL] [Abstract][Full Text] [Related]
12. Actual practice of Kochi oxydol radiation therapy for unresectable carcinomas by intra-tumoral administration of hydrogen peroxide as a radiosensitizer.
Obata S; Ishimaru Y; Miyagi S; Nakatake M; Kuroiwa A; Ohta Y; Kan T; Kanegae S; Inoue Y; Nishizato R; Miyazaki K
Mol Clin Oncol; 2022 Mar; 16(3):68. PubMed ID: 35154708
[TBL] [Abstract][Full Text] [Related]
13. Computed Tomography Demonstration of the Production and Distribution of Oxygen Gas Following Intratumoral Injection of a New Radiosensitizer (KORTUC) for Patients with Breast Cancer-Is Intratumoral Injection Not an Ideal Approach to Solve the Major Problem of Tumor Hypoxia in Radiotherapy?
Hayashi N; Ogawa Y; Kubota K; Okino K; Akima R; Morita-Tokuhiro S; Tsuzuki A; Yaogawa S; Nishioka A; Miyamura M
Cancers (Basel); 2016 Apr; 8(4):. PubMed ID: 27043633
[TBL] [Abstract][Full Text] [Related]
14. New enzyme-targeting radiosensitizer (KORTUC II) treatment for locally advanced or recurrent breast cancer.
Shimbo T; Nakata M; Yoshioka H; Sato C; Hori A; Kimura K; Iwamoto M; Yoshida K; Uesugi Y; Akiyama H; Nihei K
Mol Clin Oncol; 2021 Nov; 15(5):241. PubMed ID: 34650808
[TBL] [Abstract][Full Text] [Related]
15. [Radiation and hyperthermia in the treatment of superficial and semi-deep tumors: heat profile, heat doses, tumor remission].
Feldmann HJ; Molls M; Baumhoer W; Müller RD; Sack H
Strahlenther Onkol; 1988 Oct; 164(10):602-9. PubMed ID: 3187892
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of image-guided enzyme-targeting radiosensitization and intraoperative radiotherapy for locally advanced unresectable pancreatic cancer.
Nishioka A; Ogawa Y; Miyatake K; Tadokoro M; Nogami M; Hamada N; Kubota K; Kariya S; Kohsaki T; Saibara T; Okabayashi T; Hanazaki K
Oncol Lett; 2014 Jul; 8(1):404-408. PubMed ID: 24959285
[TBL] [Abstract][Full Text] [Related]
17. The role of surgery and radiotherapy in treatment of soft tissue sarcomas of the head and neck region: review of 30 cases.
Fayda M; Aksu G; Yaman Agaoglu F; Karadeniz A; Darendeliler E; Altun M; Hafiz G
J Craniomaxillofac Surg; 2009 Jan; 37(1):42-8. PubMed ID: 18804382
[TBL] [Abstract][Full Text] [Related]
18. [A case of retroperitoneal malignant fibrous histiocytoma with marked response to concurrent cisplatin and radiation therapy: a case report].
Abe T; Yamanaka K; Nakata W; Mori N; Sekii K; Yoshioka T; Itatani H
Hinyokika Kiyo; 2007 Apr; 53(4):241-6. PubMed ID: 17515074
[TBL] [Abstract][Full Text] [Related]
19. Reactive oxygen species-producing site in radiation and hydrogen peroxide-induced apoptosis of human peripheral T cells: Involvement of lysosomal membrane destabilization.
Ogawa Y; Kobayashi T; Nishioka A; Kariya S; Ohnishi T; Hamasato S; Seguchi H; Yoshida S
Int J Mol Med; 2004 May; 13(5):655-60. PubMed ID: 15067365
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in radiotherapy.
Munzenrider JE
Rev Interam Radiol; 1977 Jul; 2(3):123-33. PubMed ID: 408898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
